Bioinformatics analysis based on immune-related genes and immune cell infiltration of in-stent restenosis after percutaneous coronary intervention

Yufei FENG,Shan JIN,Yubing WANG,Yinfei LU,Lijuan PANG,Kejian LIU

PDF(4743 KB)
PDF(4743 KB)
J Jilin Univ Med Ed ›› 2024, Vol. 50 ›› Issue (3) : 749-758. DOI: 10.13481/j.1671-587X.20240319
Research in clinical medicine

Bioinformatics analysis based on immune-related genes and immune cell infiltration of in-stent restenosis after percutaneous coronary intervention

  • Yufei FENG1,Shan JIN2,3,Yubing WANG2,3,Yinfei LU1,Lijuan PANG2,3,4(),Kejian LIU1()
Author information +
History +

Abstract

Objective To screen the differentially expressed immune-related genes (DEIRGs) in in-stent restenosis (ISR), and to analyze the immune cell infiltration in ISR, and to clarify the mechanism of occurrence and development of ISR. Methods The mRNA gene expression data of GSE46560 dataset samples were downloaded from the Gene Expression Omnibus (GEO),and divided into ISR group and non-ISR group. The “Limma” package in R software was used to identify the differentially expressed genes (DEGs) which were then intersected with immune-related genes (IRGs) to identify the DEIRGs in ISR; R software was used for Gene Ontology (GO) functional enrichment andalysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway enrichment analysis on DEIRGs;the STRING database was used to construct the protein-protein interaction (PPI) network, which was visualized and analyzed for Hub genes by Cytoscape software; the receiver operating characteristic (ROC) curve of the Hub genes were plotted, and the area under the curve (AUC) was calculated and the diagnostic value was evaluated; CIBERSORT software was used to analyze the immune cell infiltration in ISR; Pearson correlation analysis was used to analyze the relationships between the immune cells and the relationships between the immune cells and key genes. Results A total of 331 DEGs were identified (P<0.05, | log2FC| >1), including 176 upregulated genes and 155 downregulated genes, and 38 DEIRGs were obstained. The GO functional enrichment analysis results showed that the DEIRGs were mainly enriched in biological processes (BP) such as defense response, immune response, and immune system; in cellular components (CC),the DEIRGs were located primarily in the extracellular region and cytoplasmic membrane; and in molecular functions (MF), the DEIRGs were mainly involved in regulating signaling receptor binding and cytokine receptor activity.The KEGG signaling pathway enrichment analysis results indicated that the DEIRGs in ISR were primarily enriched in the phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT) and transforming growth factor-β (TGF-β) signaling pathways. In the PPI network, CD19 had the highest node among the top 10 Hub genes. Compared with non-ISR group, the expression level of the CD19 gene in the samples in ISR group was increased (P<0.05). The AUC value in the ROC curve of CD19 gene expression was 0.92 (P<0.05). The immune cell infiltration analysis results showed that compared with non-ISR group, the infiltration level of T lymphocyte follicular helper (Tfh) cells in the patients in ISR group were increased (P<0.05), the infiltration levels of immature B lymphocytes, CD8+T lymphocytes, naive CD4+T lymphocytes, and M0 macrophages were increased, but the differences were not statistically significant (P>0.05), while the infiltration levels of memory B lymphocytes, activated memory CD4+ T lymphocytes, regulatory T cells, resting natural killer (NK) cells, activated NK cells, monocytes, resting mast cells, and neutrophils were decreased, but the differences were not statistically significant (P>0.05). There were positive correlations between Tfh cells and M0 macrophages and resting mast cells (r=0.88,P<0.05;r=0.68,P<0.05), and there were negative correlations between Tfh cells and monocytes and neutrophils(r=-0.49,P<0.05;r=-0.42,P<0.05). Conclusion CD19 may influence the occurrence and development of ISR by regulating the activation of the PI3K-AKT signaling pathway to affect the Tfh and B lymphocytes. CD19 can serve as a biomarker for the diagnosis of ISR.

Key words

In-stent restenosis / CD19 / Differentially expressed immune-related gene / Immune infiltration / Biomarker

CLC number

R392.12

Cite this article

Download Citations
Yufei FENG,Shan JIN,Yubing WANG,Yinfei LU,Lijuan PANG,Kejian LIU. Bioinformatics analysis based on immune-related genes and immune cell infiltration of in-stent restenosis after percutaneous coronary intervention. Journal of Jilin University(Medicine Edition). 2024, 50(3): 749-758 https://doi.org/10.13481/j.1671-587X.20240319

References

1 HOARE D, BUSSOOA A, NEALE S, et al. The future of cardiovascular stents: bioresorbable and integrated biosensor technology[J]. Adv Sci, 2019, 6(20): 1900856.
2 ALFONSO F, GONZALO N, RIVERO F, et al. The year in cardiovascular medicine 2020: interventional cardiology[J]. Eur Heart J, 2021, 42(10): 985-1003.
3 ULLRICH H, OLSCHEWSKI M, MüNZEL T, et al. Coronary In-stent restenosis: predictors and treatment[J]. Dtsch Arztebl Int, 2021, 118(38): 637-644.
4 YERASI C, CASE B C, FORRESTAL B J, et al. Drug-coated balloon for De Novo Coronary artery disease: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 75(9): 1061-1073.
5 NICCOLI G, MONTONE R A, SABATO V, et al. Role of allergic inflammatory cells in coronary artery disease[J]. Circulation, 2018, 138(16): 1736-1748.
6 BANAI S, FINKELSTEIN A, ALMAGOR Y, et al. Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal Alendronate with Stenting Study (BLAST)-a double blind, randomized clinical trial[J]. Am Heart J, 2013, 165(2): 234-240.
7 YAO Y, YAN Z Y, LIAN S L, et al. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma[J]. J Immunother Cancer, 2020, 8(2): e000444.
8 范吉林, 朱婷婷, 田晓玲, 等. 基于房颤中circRNA-miRNA-mRNA网络构建和免疫细胞浸润的生物信息学分析[J]. 吉林大学学报(医学版), 2022, 48(6): 1535-1545.
9 FAN J X, CAO S, CHEN M Y, et al. Investigating the AC079305/DUSP1axis as oxidative stress-related signatures and immune infiltration characteristics in ischemic stroke[J]. Oxid Med Cell Longev, 2022, 2022: 8432352.
10 张德洪, 郑明珠, 李家秋, 等. 基于MSR1 mRNA和蛋白在泛癌组织中表达的生物信息学分析及其意义[J]. 吉林大学学报(医学版), 2023, 49(2): 425-439.
11 赵志娟, 孟 莲, 刘春霞. 基于融合基因作用于横纹肌肉瘤的miRNA-mRNA调控网络的生物信息学分析[J]. 吉林大学学报(医学版), 2022, 48(1): 154-162.
12 GIUSTINO G, COLOMBO A, CAMAJ A, et al. Coronary In-stent restenosis: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2022, 80(4): 348-372.
13 COLLET C, GRUNDEKEN M J, ASANO T, et al. State of the art: coronary angiography[J]. EuroIntervention, 2017, 13(6): 634-643.
14 DEMYANETS S, TENTZERIS I, JARAI R, et al. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis[J]. Cytokine, 2014, 67(2): 65-70.
15 SCHILLINGER M, MINAR E. Restenosis after percutaneous angioplasty: the role of vascular inflammation[J]. Vasc Health Risk Manag, 2005, 1(1): 73-78.
16 DEL PORTO F, CIFANI N, PROIETTA M, et al. Lag3+ regulatory T lymphocytes in critical carotid artery stenosis[J]. Clin Exp Med, 2019, 19(4): 463-468.
17 DEL PORTO F, CIFANI N, PROIETTA M, et al. Regulatory T CD4+?CD25+ lymphocytes increase in symptomatic carotid artery stenosis[J]. Ann Med, 2017, 49(4): 283-290.
18 LI Q Q, LI Y T, HUANG W, et al. Loss of lipocalin 10 exacerbates diabetes-induced cardiomyopathy via disruption of Nr4a1-mediated anti-inflammatory response in macrophages[J]. Front Immunol, 2022, 13: 930397.
19 HAOHAN S, PUSSADHAMMA B, JUMNAINSONG A, et al. Association of major histocompatibility complex class I related chain A/B positive microparticles with acute myocardial infarction and disease severity[J]. Diagnostics, 2020, 10(10): 766.
20 GORCZYNSKI R M. IL-17 signaling in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1240: 47-58.
21 DI SALVO T G, YANG K C, BRITTAIN E, et al. Right ventricular myocardial biomarkers in human heart failure[J]. J Card Fail, 2015, 21(5): 398-411.
22 ALIMADADI A, MUNROE P B, JOE B, et al. Meta-analysis of dilated cardiomyopathy using cardiac RNA-seq transcriptomic datasets[J]. Genes, 2020, 11(1): 60.
23 ZHANG B, YAO R J, HU C, et al. Epigallocatechin gallate mediated sandwich-like coating for mimicking endothelium with sustained therapeutic nitric oxide generation and heparin release[J]. Biomaterials, 2021, 269: 120418.
24 LU H K, HUANG Y, LIANG X Y, et al. Pinellia ternata attenuates carotid artery intimal hyperplasia and increases endothelial progenitor cell activity via the PI3K/Akt signalling pathway in wire-injured rats[J]. Pharm Biol, 2020, 58(1): 1184-1191.
25 TANG Z H, WANG Y, FAN Y B, et al. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries[J]. Circulation, 2008, 118(7): 764-772.
26 KHAN R, AGROTIS A, BOBIK A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury[J]. Cardiovasc Res, 2007, 74(2): 223-234.
27 WANG S X, LINCOLN T M, MURPHY-ULLRICH J E. Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta}activity in vascular smooth muscle cells[J]. Am J Physiol Cell Physiol, 2010, 298(5): C1188-C1197.
28 LI X C, DING Y, ZI M T, et al. CD19, from bench to bedside[J]. Immunol Lett, 2017, 183: 86-95.
29 WENG R Q, LIU S D, GU X D, et al. Clonal diversity of the B cell receptor repertoire in patients with coronary in-stent restenosis and type 2 diabetes[J]. Open Life Sci, 2021, 16(1): 884-898.
30 FUJIMOTO M, POE J C, HASEGAWA M, et al. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification[J]. Immunol Res, 2000, 22(2/3): 281-298.
31 FUJIMOTO M, FUJIMOTO Y, POE J C, et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification[J]. Immunity, 2000, 13(1): 47-57.
32 DEVEZA R C, ELKINS M, SARAGIOTTO B T. PEDro systematic review update: exercise for coronary heart disease[J]. Br J Sports Med, 2017, 51(9): 755-756.
33 CHOE N, KWON J S, KIM Y S, et al. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor[J]. Cell Signal, 2015, 27(6): 1056-1065.
34 CROTTY S. T follicular helper cell biology: a decade of discovery and diseases[J]. Immunity, 2019, 50(5): 1132-1148.
35 PREITE S, HUANG B, CANNONS J L, et al. PI3K orchestrates T follicular helper cell differentiation in a context dependent manner: implications for autoimmunity[J]. Front Immunol, 2018, 9: 3079.

Comments

PDF(4743 KB)

Accesses

Citation

Detail

Sections
Recommended

/